AHK-Cu
Ala-His-Lys copper complex
AHK-Cu is the copper complex of alanyl-histidyl-lysine. Its first residue is alanine, unlike the glycine in GHK-Cu; the two names therefore describe different complexes.
Reviewed September 2026
- Residues
- 3. verified: 3 residues per peptide ligand; this is not an assertion about ligand-to-copper stoichiometry.
- Average mass
- Not established. unverified: No unique average molecular mass assigned without a specified AHK–Cu coordination/protonation/salt form. The retrieved PubChem name match includes hydrochloride and is not adopted as the reference by assumption.
- pI
- Not established. unverified: Metal binding changes protonation and charge. A free GHK/AHK peptide pI does not describe the copper complex; no validated complex-specific model or measured value was established.
Reference details
| Residues | 3 |
|---|---|
| Average mass | Not established |
| pI | Not established |
| Aliases | Ala-His-Lys copper complex |
|---|---|
| Research area | Dermal |
Property basis and sources
These describe the reference compound or formulation, not identification or testing of the supplied lot.
AHK–Cu designates an alanyl–histidyl–lysine/copper complex. Copper stoichiometry, protonation, counterions and hydration require specification; a hydrochloride database synonym is not proof of the sold form.
- Residues: 3 (verified). 3 residues per peptide ligand; this is not an assertion about ligand-to-copper stoichiometry. Residues source 1
- Average mass: Not established (unverified). No unique average molecular mass assigned without a specified AHK–Cu coordination/protonation/salt form. The retrieved PubChem name match includes hydrochloride and is not adopted as the reference by assumption. Average mass source 1 Average mass source 2
- pI: Not established (unverified). Metal binding changes protonation and charge. A free GHK/AHK peptide pI does not describe the copper complex; no validated complex-specific model or measured value was established. pI source 1
Reference scope and linked records
Reference type: Peptide-metal complex.
This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.
Catalogue context: AHK-CU. The product retains its own name and specification; this link does not certify equivalence to published study material.
Related references
Sources and their scope
- Effect of tripeptide-copper complex on human hair growth in vitro. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.
About AHK-Cu
Identity and context
The primary hair-follicle study explicitly identifies L-alanyl-L-histidyl-L-lysine-Cu2+. This is enough to distinguish the ligand from GHK, but a supplier specification still needs to define the complex and chemical form of the delivered material.
Reference classification
Peptide-metal complex. The linked catalogue product is AHK-CU. This reference does not independently authenticate the material supplied.
Storage and handling
Analytical specification
Check that the ligand is AHK rather than GHK and that the copper specification is included. A total powder amount does not state copper content, ligand content or the ratio between them.
Storage and experimental handling
Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.
Research evidence
| Area | Summary | Evidence |
|---|---|---|
| What the source examines | Pyo and colleagues studied isolated human hair follicles ex vivo and cultured dermal papilla cells. They reported follicle elongation and cell proliferation under the tested conditions. The reduction in apoptotic cells was not statistically significant, a qualification that should remain attached to that part of the result. | Source context |
| What cannot be inferred | Human-derived cells or follicles are not a clinical hair-regrowth trial. The study cannot establish a treatment outcome in people or validate the identity of an unrelated catalogue lot. | Evidence limits |
References
Sources used for the data on this page, checked September 2026.
- Effect of tripeptide-copper complex on human hair growth in vitroPrimary source for the reference discussion; not lot-specific product evidence.
Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.